Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice, Journal of Leukocyte Biology, October 2006, Society for Leukocyte Biology,
DOI: 10.1189/jlb.0306173.
You can read the full text:
Contributors
The following have contributed to this page